41st treatment shown to reduce risk in
June 2022, now with p = 0.046 from 13 studies, recognized in 10 countries.
Lower risk for cases and viral clearance.
No treatment is 100% effective. Protocols
combine treatments.
5,700+ studies for
169 treatments. c19early.org
|
|
risk of case, 75.0% lower, RR 0.25, p < 0.001, treatment 13 of 203 (6.4%), control 108 of 422 (25.6%), NNT 5.2.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
